Developer docs
API playgroundTry for free, no card

Search company profiles

Centre Hospitalier de Luxembourg

Full company profile

uuid000vfab

Namestring
Centre Hospitalier de Luxembourg
Legal namestring
Centre Hospitalier de Luxembourg
Websiteurl
chl.lu
Company typeenum
Private
Founded yearint
1976
Descriptiontext

Centre Hospitalier de Luxembourg (CHL) is the principal public hospital establishment (établissement public) of Luxembourg, founded in 1976 and operated by the Luxembourg state under a Commission Administrative with a Director General at the helm. Headquartered at 4 rue Ernest Barblé in Luxembourg City, CHL runs a multi-site network comprising CHL Centre (main acute-care hospital), CHL Eich (acute geriatrics, palliative care, sports medicine, rehabilitation), CHL Maternité Grande-Duchesse Charlotte (obstetrics, gynecology, neonatology), and CHL KannerKlinik (comprehensive pediatric services from neonatology to pediatric oncology and pediatric cardiology). The hospital also operates four Praxiszentren community satellites in Grevenmacher, Mersch, Marnach, and Steinfort, with the Grevenmacher site promoted to an official additional hospital site as of January 2026. CHL serves the general population of Luxembourg across more than 60 clinical departments, with depth in oncology, pediatrics, maternity, geriatrics, sports medicine, and rare diseases, and acts as the National Hub for Rare Diseases under European Reference Networks.

CHL's operating backbone combines conventional hospital information systems with advanced medical technology platforms: two Omni Legend digital PET-CT scanners and a hot-laboratory radiopharmacy at the Centre National PET (inaugurated December 2025), Luxembourg's first bi-plan angiography room (July 2023), digital mammography, and specialized facilities for CAR-T cell therapy (approved for myeloma, February 2026). The hospital operates an LCTR-Clinical Research Luxembourg translational research facility and conducts joint research with the Luxembourg Institute of Health, with publications including a New England Journal of Medicine lung cancer study. CHL's compliance footprint includes three consecutive Joint Commission International (JCI) accreditations (the first hospital in Luxembourg to achieve this), multiple ISO 9001 certifications across its Centre National PET, Dialysis, Senology, Sterilization, and Laboratory services, with the National PMA Laboratory progressing toward ISO 15189 accreditation.

Revenue is generated primarily through the Luxembourg national health insurance (CNS) framework under fee-for-service billing for consultations, procedures, hospitalizations, and treatments, with supplementary income from public grants, philanthropy (donation program in operation), research collaborations, and partnership work such as the 2015 COSL Olympic sports-medicine convention. Specific revenue figures are not publicly disclosed, consistent with the institution's status as a state-owned établissement public rather than an investor-backed entity. Operational scale indicators include record deliveries at Maternité (surpassing 2,000 annually in 2013), growing mammography volume (3,371 exams in Q1 2023, up 13% from 2021), and a workforce in the 1,001–5,000 employee band. The distribution model is direct-to-patient across physical sites, augmented by online appointment booking, a MedNews newsletter for healthcare professionals, and a PatientenHouse patient resource center coordinating 26 patient associations.

Short descriptiontext

Centre Hospitalier de Luxembourg is the principal state-owned public hospital establishment of Luxembourg, operating four main sites and four satellite clinics. Founded 1976, it provides acute, maternity, pediatric, oncology, and specialty care to the national population across 60+ clinical departments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersLuxembourg, Luxembourg
HQ citystring
Luxembourg
HQ countrystring
Luxembourg
HQ regionstring
Europe
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hospital services, acute care, maternity services, pediatric care, nuclear imaging
NAICS code4 codes
  • General Medical and Surgical Hospitals6221
  • Hospitals622
  • Medical and Diagnostic Laboratories6215
  • Ambulatory Health Care Services621
SIC code4 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Medical Laboratories8071
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Public Hospital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Services Revenue
TypeSubscription Recurring
Description

As a public hospital, CHL generates revenue through the Luxembourg national health insurance system, billing patients and insurance providers for medical consultations, procedures, hospitalizations, and treatments according to national fee schedules.

chl.lu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Others
Pricing details1 tier
1Standard hospital services
ModelOtherBilling cadencePay-as-you-go
Notes

Public hospital billing based on national health insurance rates; first-class room upgrades available at additional cost

chl.lu
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

CHL is a multi-site public hospital establishment providing comprehensive diagnostic, treatment, hospitalization, and emergency services across more than 60 clinical departments through four main hospital sites and four regional satellite clinics in Luxembourg. Its portfolio spans acute care, specialized maternity and pediatric care, oncology, nuclear imaging (PET-CT), sports medicine, rehabilitation, and clinical research, serving the general population of Luxembourg as well as cross-border patients via European Reference Networks.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Achieved triple consecutive JCI accreditation, first hospital in Luxembourg
+2 more records
Product overview1 text field

Centre Hospitalier de Luxembourg operates as a multi-site public hospital system comprising CHL Centre (main acute care hospital), CHL Eich (geriatric/rehabilitation), CHL Maternité (maternity/women's health), and CHL KannerKlinik (pediatrics). The hospital also operates the Praxiszentren regional outpatient network. Specialized services include the Centre National PET (nuclear imaging), LCTR clinical research facility, PatientenHouse patient support center, and OBEDIA-Kids national competence network for pediatric diabetes/obesity. Advanced therapies include CAR-T cell therapy for cancer treatment. The hospital provides comprehensive medical services across more than 60 clinical departments.

Product and service1 record
1CHL Centre (Main Acute Care Hospital)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-03
Description

National competence network dedicated to diabetes and obesity with comorbidity in children and adolescents, inaugurated March 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-07
Description

Convention signed in June 2024 to mutualize hospital laboratory activities between CHL and CHdN, combining resources and expertise for improved diagnostic services across Luxembourg.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-19
Description

Partnership strengthened in October 2023 to enhance teaching and research collaboration between CHL and University of Luxembourg. Includes joint research initiatives, clinical training for medical students, and shared research facilities.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2015-12-21
Description

Cooperation convention signed December 2015 to provide quality sports medicine and physiotherapy services for Olympic athletes. CHL Clinique du Sport supports COSL athletes and federations with specialized medical care for prevention, therapy, and rehabilitation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple collaborations including tele-pathology (directly connected systems) and electronic transmission of analysis reports. Joint efforts in laboratory analyses and public health testing campaigns.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research partnership for clinical and translational research. Joint participation in international medical studies including lung cancer research published in New England Journal of Medicine.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

CHL serves as National Hub for Rare Diseases as part of European Reference Networks, connecting Luxembourg patients to specialized care across Europe through virtual platforms.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Historical research partnership for sports medicine research, cancer studies, and clinical trials including participation in NEJM-published international lung cancer study.

Recent move15 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Luxembourg's public biomedical research organization, formerly CRP-Santé. LIH collaborates with CHL on clinical and translational research including NEJM-published international studies, functioning as a research partner rather than a service competitor.

2Hôpital Universitaire de Bruxelles (HUB - Erasme / Bordet)
TypeBroad incumbent
Description

Belgian academic hospital group combining Erasme and Jules Bordet. Comparable in providing university-level care, oncology reference center status, and clinical research infrastructure, and is a common referral destination for Luxembourg patients.

TypeBroad incumbent
Description

Major French university hospital serving the cross-border Greater Region. Comparable to CHL in providing academic medicine and serving as a regional referral center, with direct competition for complex cases originating from southern Luxembourg.

TypeBroad incumbent
Description

German university hospital in the Saarland bordering Luxembourg. Provides academic and tertiary care that overlaps with CHL's scope and competes for German-speaking cross-border patients from the eastern Luxembourg catchment.

TypeBroad incumbent
Description

Large German university hospital comparable in academic scope, multi-site operations, and research output. Provides a benchmark for what CHL aspires to in academic medicine within a smaller population catchment.

TypeRegional player
Description

Luxembourg hospital group operating sites in Esch-sur-Alzette, Dudelange, and Niederkorn. Competes with CHL in southern Luxembourg and offers overlapping emergency, surgical, and geriatric services within the same national system.

7Hôpitaux Robert Schuman (HRS)
TypeDirect peer
Description

Luxembourg non-profit hospital group operating Hôpital Kirchberg, ZithaKlinik, and Clinique Bohler. HRS is the principal private/non-profit competitor to CHL within Luxembourg, offering overlapping acute, maternity, and surgical services in the same catchment.

8Centre Hospitalier Universitaire de Liège (CHU Liège)
TypeBroad incumbent
Description

Belgian university hospital center with comparable scope (academic, multi-site, regional referral role). As a cross-border alternative for complex cases from Luxembourg, CHU Liège competes with CHL for high-acuity patient flow in the Greater Region.

TypeOthers
Description

Luxembourg's national public health laboratory and reference testing institution. LNS is a strategic partner of CHL for tele-pathology, electronic transmission of analysis reports, and joint public-health testing campaigns, making it an adjacent ecosystem participant rather than a competitor.

TypeDirect peer
Description

Luxembourg's other principal public hospital, also operating under the Luxembourg national health system. CHdN signed a 2024 convention with CHL to mutualize hospital laboratory activities, making it the closest direct comparable by geography, ownership, and service mix.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Centre Hospitalier de Luxembourg

Public Hospital Serviceschl.lu

Centre Hospitalier de Luxembourg is the principal state-owned public hospital establishment of Luxembourg, operating four main sites and four satellite clinics. Founded 1976, it provides acute, maternity, pediatric, oncology, and specialty care to the national population across 60+ clinical departments.

What Centre Hospitalier de Luxembourg does

Centre Hospitalier de Luxembourg (CHL) is the principal public hospital establishment (établissement public) of Luxembourg, founded in 1976 and operated by the Luxembourg state under a Commission Administrative with a Director General at the helm. Headquartered at 4 rue Ernest Barblé in Luxembourg City, CHL runs a multi-site network comprising CHL Centre (main acute-care hospital), CHL Eich (acute geriatrics, palliative care, sports medicine, rehabilitation), CHL Maternité Grande-Duchesse Charlotte (obstetrics, gynecology, neonatology), and CHL KannerKlinik (comprehensive pediatric services from neonatology to pediatric oncology and pediatric cardiology). The hospital also operates four Praxiszentren community satellites in Grevenmacher, Mersch, Marnach, and Steinfort, with the Grevenmacher site promoted to an official additional hospital site as of January 2026. CHL serves the general population of Luxembourg across more than 60 clinical departments, with depth in oncology, pediatrics, maternity, geriatrics, sports medicine, and rare diseases, and acts as the National Hub for Rare Diseases under European Reference Networks.

CHL's operating backbone combines conventional hospital information systems with advanced medical technology platforms: two Omni Legend digital PET-CT scanners and a hot-laboratory radiopharmacy at the Centre National PET (inaugurated December 2025), Luxembourg's first bi-plan angiography room (July 2023), digital mammography, and specialized facilities for CAR-T cell therapy (approved for myeloma, February 2026). The hospital operates an LCTR-Clinical Research Luxembourg translational research facility and conducts joint research with the Luxembourg Institute of Health, with publications including a New England Journal of Medicine lung cancer study. CHL's compliance footprint includes three consecutive Joint Commission International (JCI) accreditations (the first hospital in Luxembourg to achieve this), multiple ISO 9001 certifications across its Centre National PET, Dialysis, Senology, Sterilization, and Laboratory services, with the National PMA Laboratory progressing toward ISO 15189 accreditation.

Revenue is generated primarily through the Luxembourg national health insurance (CNS) framework under fee-for-service billing for consultations, procedures, hospitalizations, and treatments, with supplementary income from public grants, philanthropy (donation program in operation), research collaborations, and partnership work such as the 2015 COSL Olympic sports-medicine convention. Specific revenue figures are not publicly disclosed, consistent with the institution's status as a state-owned établissement public rather than an investor-backed entity. Operational scale indicators include record deliveries at Maternité (surpassing 2,000 annually in 2013), growing mammography volume (3,371 exams in Q1 2023, up 13% from 2021), and a workforce in the 1,001–5,000 employee band. The distribution model is direct-to-patient across physical sites, augmented by online appointment booking, a MedNews newsletter for healthcare professionals, and a PatientenHouse patient resource center coordinating 26 patient associations.

Centre Hospitalier de Luxembourg firmographics

Firmographics
Name
Centre Hospitalier de Luxembourg
Legal name
Centre Hospitalier de Luxembourg
Website
https://chl.lu
Company type
Private
Founded year
1976
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Centre Hospitalier de Luxembourg is the principal state-owned public hospital establishment of Luxembourg, operating four main sites and four satellite clinics. Founded 1976, it provides acute, maternity, pediatric, oncology, and specialty care to the national population across 60+ clinical departments.
Ownership category
akta.pro rank

Where Centre Hospitalier de Luxembourg is headquartered

Location

Headquarters

HQ city
Luxembourg
HQ country
Luxembourg
HQ region
Europe

Offices8 records

Markets served

Centre Hospitalier de Luxembourg business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Others

Revenue model

  1. Healthcare Services Revenue: As a public hospital, CHL generates revenue through the Luxembourg national health insurance system, billing patients and insurance providers for medical consultations, procedures, hospitalizations, and treatments according to national fee schedules.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStandard hospital services

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Centre Hospitalier de Luxembourg product offering

Product offering

Core offering

CHL is a multi-site public hospital establishment providing comprehensive diagnostic, treatment, hospitalization, and emergency services across more than 60 clinical departments through four main hospital sites and four regional satellite clinics in Luxembourg. Its portfolio spans acute care, specialized maternity and pediatric care, oncology, nuclear imaging (PET-CT), sports medicine, rehabilitation, and clinical research, serving the general population of Luxembourg as well as cross-border patients via European Reference Networks.

Product overview

Centre Hospitalier de Luxembourg operates as a multi-site public hospital system comprising CHL Centre (main acute care hospital), CHL Eich (geriatric/rehabilitation), CHL Maternité (maternity/women's health), and CHL KannerKlinik (pediatrics). The hospital also operates the Praxiszentren regional outpatient network. Specialized services include the Centre National PET (nuclear imaging), LCTR clinical research facility, PatientenHouse patient support center, and OBEDIA-Kids national competence network for pediatric diabetes/obesity. Advanced therapies include CAR-T cell therapy for cancer treatment. The hospital provides comprehensive medical services across more than 60 clinical departments.

Differentiator

Problem solved

Functional benefit

Products and services

  • CHL Centre (Main Acute Care Hospital)

Quantifiable outcome

  • Achieved triple consecutive JCI accreditation, first hospital in Luxembourg
  • +2 more outcomes

Companies that use Centre Hospitalier de Luxembourg

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Centre Hospitalier de Luxembourg technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Centre Hospitalier de Luxembourg partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor, core and major.

  • OBEDIA-Kids NetworkminorStrategic or Co-development Partner · 3 March 2026National competence network dedicated to diabetes and obesity with comorbidity in children and adolescents, inaugurated March 2026.
  • Centre Hospitalier du Nord (CHdN)coreStrategic or Co-development Partner · 7 June 2024Convention signed in June 2024 to mutualize hospital laboratory activities between CHL and CHdN, combining resources and expertise for improved diagnostic services across Luxembourg.
  • University of LuxembourgcoreStrategic or Co-development Partner · 19 October 2023Partnership strengthened in October 2023 to enhance teaching and research collaboration between CHL and University of Luxembourg. Includes joint research initiatives, clinical training for medical students, and shared research facilities.
  • Comité Olympique et Sportif Luxembourgeois (COSL)majorStrategic or Co-development Partner · 21 December 2015Cooperation convention signed December 2015 to provide quality sports medicine and physiotherapy services for Olympic athletes. CHL Clinique du Sport supports COSL athletes and federations with specialized medical care for prevention, therapy, and rehabilitation.
  • Laboratoire National de Santé (LNS)coreStrategic or Co-development PartnerMultiple collaborations including tele-pathology (directly connected systems) and electronic transmission of analysis reports. Joint efforts in laboratory analyses and public health testing campaigns.
  • Luxembourg Institute of Health (LIH)coreStrategic or Co-development PartnerCollaborative research partnership for clinical and translational research. Joint participation in international medical studies including lung cancer research published in New England Journal of Medicine.
  • European Reference Networks (ERN)majorStrategic or Co-development PartnerCHL serves as National Hub for Rare Diseases as part of European Reference Networks, connecting Luxembourg patients to specialized care across Europe through virtual platforms.
  • CRP-Santé (now LIH)majorStrategic or Co-development PartnerHistorical research partnership for sports medicine research, cancer studies, and clinical trials including participation in NEJM-published international lung cancer study.

Scale indicators4 records

Recent moves15 records

Expansion highlights6 records

Centre Hospitalier de Luxembourg competitors and assessment

Company assessment

Others

  • Luxembourg Institute of Health (LIH): Luxembourg's public biomedical research organization, formerly CRP-Santé. LIH collaborates with CHL on clinical and translational research including NEJM-published international studies, functioning as a research partner rather than a service competitor.
  • Laboratoire National de Santé (LNS): Luxembourg's national public health laboratory and reference testing institution. LNS is a strategic partner of CHL for tele-pathology, electronic transmission of analysis reports, and joint public-health testing campaigns, making it an adjacent ecosystem participant rather than a competitor.

Broad incumbents

  • Hôpital Universitaire de Bruxelles (HUB - Erasme / Bordet): Belgian academic hospital group combining Erasme and Jules Bordet. Comparable in providing university-level care, oncology reference center status, and clinical research infrastructure, and is a common referral destination for Luxembourg patients.
  • Hôpitaux Universitaires de Strasbourg (CHU Strasbourg): Major French university hospital serving the cross-border Greater Region. Comparable to CHL in providing academic medicine and serving as a regional referral center, with direct competition for complex cases originating from southern Luxembourg.
  • Universitätsklinikum des Saarlandes (UKS Homburg): German university hospital in the Saarland bordering Luxembourg. Provides academic and tertiary care that overlaps with CHL's scope and competes for German-speaking cross-border patients from the eastern Luxembourg catchment.
  • Klinikum der Universität München (LMU Klinikum): Large German university hospital comparable in academic scope, multi-site operations, and research output. Provides a benchmark for what CHL aspires to in academic medicine within a smaller population catchment.
  • Centre Hospitalier Universitaire de Liège (CHU Liège): Belgian university hospital center with comparable scope (academic, multi-site, regional referral role). As a cross-border alternative for complex cases from Luxembourg, CHU Liège competes with CHL for high-acuity patient flow in the Greater Region.

Regional players

  • Centre Hospitalier Emile Mayrisch (CHEM): Luxembourg hospital group operating sites in Esch-sur-Alzette, Dudelange, and Niederkorn. Competes with CHL in southern Luxembourg and offers overlapping emergency, surgical, and geriatric services within the same national system.

Direct peers

  • Hôpitaux Robert Schuman (HRS): Luxembourg non-profit hospital group operating Hôpital Kirchberg, ZithaKlinik, and Clinique Bohler. HRS is the principal private/non-profit competitor to CHL within Luxembourg, offering overlapping acute, maternity, and surgical services in the same catchment.
  • Centre Hospitalier du Nord (CHdN): Luxembourg's other principal public hospital, also operating under the Luxembourg national health system. CHdN signed a 2024 convention with CHL to mutualize hospital laboratory activities, making it the closest direct comparable by geography, ownership, and service mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Centre Hospitalier de Luxembourg social profiles

Digital presence

Centre Hospitalier de Luxembourg compliance and trust

Trust signal

Compliance5 records

Centre Hospitalier de Luxembourg financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Centre Hospitalier de Luxembourg leadership team

Management profile

Number of profiles

Profiles5 records

Centre Hospitalier de Luxembourg funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Centre Hospitalier de Luxembourg M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre Hospitalier de Luxembourg

What does Centre Hospitalier de Luxembourg do?

CHL is a multi-site public hospital establishment providing comprehensive diagnostic, treatment, hospitalization, and emergency services across more than 60 clinical departments through four main hospital sites and four regional satellite clinics in Luxembourg. Its portfolio spans acute care, specialized maternity and pediatric care, oncology, nuclear imaging (PET-CT), sports medicine, rehabilitation, and clinical research, serving the general population of Luxembourg as well as cross-border patients via European Reference Networks.

Is Centre Hospitalier de Luxembourg a public or private company?

Centre Hospitalier de Luxembourg is a private company. It is classified as state government owned and is currently operating.

When was Centre Hospitalier de Luxembourg founded?

Centre Hospitalier de Luxembourg was founded in 1976. It employs 1,001 to 5,000 people.

Where is Centre Hospitalier de Luxembourg based?

Centre Hospitalier de Luxembourg is headquartered in Luxembourg, Luxembourg, in the Europe region.

How does Centre Hospitalier de Luxembourg make money?

One revenue line is on record: healthcare Services Revenue.

Who are Centre Hospitalier de Luxembourg's main competitors?

Others on record are Luxembourg Institute of Health (LIH) and Laboratoire National de Santé (LNS). Broad incumbents are Hôpital Universitaire de Bruxelles (HUB - Erasme / Bordet), Hôpitaux Universitaires de Strasbourg (CHU Strasbourg), Universitätsklinikum des Saarlandes (UKS Homburg), Klinikum der Universität München (LMU Klinikum) and Centre Hospitalier Universitaire de Liège (CHU Liège). Centre Hospitalier Emile Mayrisch (CHEM) is listed as a regional player. Direct peers are Hôpitaux Robert Schuman (HRS) and Centre Hospitalier du Nord (CHdN).

Does Centre Hospitalier de Luxembourg have an API?

No public API is recorded for Centre Hospitalier de Luxembourg.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SiliconluxembourgBuilt To Move: How To Boost The Resilience Of Healthcare SystemsAt Healthcare Week Luxembourg, experts discussed building resilient healthcare systems, citing cyber risk and resource shortages as top threats. The Luxembourg Hospital Federation study identified these as the leading risks, while speakers emphasized adaptive governance and learning from crises.SiliconluxembourgCAR-T Cell Therapy: “A real revolution” For Cancer TreatmentThe Centre Hospitalier de Luxembourg announced in February the first CAR-T cell authorisation for myeloma patients in the country, expanding on previous approvals for leukaemia and lymphoma in 2024. The treatment, which modifies a patient's own T-cells to recognise and attack cancer cells, achieves long-term responses in 30-40% of heavily pretreated patients with manageable side effects. A clinician-scientist at CHL is advocating for Luxembourg to establish local CAR-T cell manufacturing capabilities and a GMP-certified facility to decrease costs and transform the country's biotech landscape.PR NewswireMicrobiome and Diabetes: Sick or healthy? Bacterial Metabolism Tells us Which - and WhyResearchers at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, in collaboration with IBBL, Centre Hospitalier de Luxembourg, and Centre Hospitalier Emile Mayrisch, have developed a new multi-omics approach to study the gut microbiome by simultaneously analyzing DNA, RNA, and proteins. Their MUST study found that while the bacterial species composition in the gut hardly differs between type 1 diabetes patients and healthy individuals, the metabolic activity of those bacteria—including genes switched on or off and protein production such as thiamine—varies significantly. The findings, published in Nature Microbiology, may help identify biomarkers for earlier diagnosis of diabetes, potentially allowing for earlier therapeutic intervention.